Just 2 clarify #SanofiFR do NOT warn permanent alopecia from #taxotere on product info on their website.Patients in EU are NOT being warned. pic.twitter.com/q7rsBPGUuF
— S.A.Ledlie (@SALedlie) November 2, 2017
If two drugs had relatively similar outcomes, but one caused permanent hair loss, which would you choose?
The answer is clear. But most patients weren’t given that option.
The selection of Taxotere over Taxol would not have been important except for the fact that Taxotere causes Permanent Hair Loss (Alopecia) in up to 12% of women according to some studies. Taxol does not cause Permanent Hair Loss in any noticeable numbers.
Learn More
Shirley Ledlie, a breast cancer survivor, and recipient of Taxotere, has written a book about her experiences. She also is active in supporting women fighting breast cancer, alopecia, and speaking out about Taxotere and appropriate product label warnings about the risk of permanent hair loss.
This is Shirley Ledlie’s book, and special offer:
PROMO- 99c kindle book https://t.co/xBhfN4HEaU How I took on the giants of #bigpharma the search for the truth #Taxotere
— S.A.Ledlie (@SALedlie) October 24, 2017